NCT05182749: Safety and Efficacy of the Bacteriophage Preparation, ShigActiveâ„¢, in a Human Experimental Model of Shigellosis |
|
|
| Active, not recruiting | 1/2 | 52 | US | bacteriophage, ShigActive, Placebo, Phosphate Buffered Saline | Intralytix, Inc., University of Maryland, Baltimore | Shigellosis | 12/24 | 06/25 | | |